Default: Theranostics

ISSN:

Journal Home

Journal Guideline

Theranostics Q1 Unclaimed

Ivyspring International Publisher Australia
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Theranostics is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 136. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1525 €. The scope of the journal is focused on in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, personalized medicine. It has an SJR impact factor of 2,381 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,381.

Theranostics focuses its scope in these topics and keywords: cancer, nanoparticles, vivo, theranostic, tumor, breast, imaging, receptors, effect, activity, ...

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1525 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Theranostics

2,381

SJR Impact factor

136

H Index

481

Total Docs (Last Year)

1936

Total Docs (3 years)

36518

Total Refs

23868

Total Cites (3 years)

1936

Citable Docs (3 years)

12.06

Cites/Doc (2 years)

75.92

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, nanoparticles, vivo, theranostic, tumor, breast, imaging, receptors, effect, activity, hep, growth, inhibitorsglioma, glucose, genes, foetida, biomarkers, blocking, enhances, enable, cell, dualtargeting, dots, differentiation, deliverythe, deliver, booster, clinical, cimicifuga, cervical, cellspecific, cationic, in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, personalized medicine

FAQS